Back to top
more

Select Medical (SEM)

(Delayed Data from NYSE)

$33.40 USD

33.40
362,449

+0.15 (0.45%)

Updated May 29, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (73 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

New Strong Buy Stocks for March 2nd

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.

Urmimala Biswas headshot

5 Excellent GARP Stocks Based on Low PEG Ratio

by Urmimala Biswas

Here are five of the 74 GARP stocks that qualify the screening.

Select Medical (SEM) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Select Medical (SEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.

Encompass Health (EHC) Unveils Plans to Expand in Maryland

by Zacks Equity Research

Encompass Health's (EHC) plans to construct a hospital is indicative of the company's efforts to offer improved healthcare services in southern Maryland.

Earnings Preview: Select Medical (SEM) Q4 Earnings Expected to Decline

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Select Medical (SEM) Rides on a Diversified Business Profile

by Zacks Equity Research

Select Medical's (SEM) supremacy in a fragmented market and its affordable healthcare services in each of its business segments bode well for the long haul.

Srijita Guha headshot

3 Health Insurers That Crushed S&P YTD, Set to Rise Further

by Srijita Guha

We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.

    Is Select Medical (SEM) a Suitable Stock for Value Investors?

    by Zacks Equity Research

    Let's see if Select Medical (SEM) stock is a good choice for value-oriented investors right now from multiple angles.

    Improving Patient Volumes Aid Select Medical's (SEM) Prospects

    by Zacks Equity Research

    Recovery in patient volumes owing to relaxation of government-imposed constraints is gradually restoring the patient admissions, thereby reinstating Select Medical (SEM) on the growth path.

    Select Medical's (SEM) Q3 Earnings Beat Mark, Improve Y/Y

    by Zacks Equity Research

    Select Medical's (SEM) third-quarter 2020 earnings gain traction from better revenues at its Critical Illness Recovery and Rehabilitation Hospital segments.

    Select Medical (SEM) Q3 Earnings and Revenues Beat Estimates

    by Zacks Equity Research

    Select Medical (SEM) delivered earnings and revenue surprises of 86.67% and 5.24%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

    Select Medical (SEM) is a Great Momentum Stock: Should You Buy?

    by Zacks Equity Research

    Does Select Medical (SEM) have what it takes to be a top stock pick for momentum investors? Let's find out.

    Universal Health (UHS) to Report Q3 Results: What to Expect

    by Zacks Equity Research

    Universal Health's (UHS) third-quarter earnings results are likely to reflect depressed revenues and weak admissions.

    Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues

    by Zacks Equity Research

    Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.

    Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?

    by Zacks Equity Research

    Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.

    Will Covid-Led Higher Demand Aid Teladoc's (TDOC) Q3 Earnings?

    by Zacks Equity Research

    A surge in demand for virtual health care services is likely to have contributed to Teladoc's (TDOC) earnings in Q3

    Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for

    by Zacks Equity Research

    Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Top Ranked Growth Stocks to Buy for September 29th

    by Zacks Equity Research

    Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 29th

    Select Medical Enters Into Joint Venture With Rush University

    by Zacks Equity Research

    Select Medical (SEM) forms a joint venture with Rush University to manage healthcare operations at facilities in Chicago and Northwest Indiana area.

    Centene (CNC) Offers Senior Unsecured Notes Valued $2.2B

    by Zacks Equity Research

    Centene (CNC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.

    Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY

    by Zacks Equity Research

    Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY

    Rimmi Singhi headshot

    5 Must-Buy Stocks Offering High Earnings Yield

    by Rimmi Singhi

    The earnings potential of a stock is an important consideration while making investment decisions. This makes the earnings yield ratio a handy tool for stock selection.

    Top Ranked Growth Stocks to Buy for September 21st

    by Zacks Equity Research

    Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 21st

    Top Ranked Growth Stocks to Buy for September 17th

    by Zacks Equity Research

    Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 17th